KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2019 - 2025)

Rigel Pharmaceuticals has reported Interest Coverage Ratio over the past 9 years, most recently at 13.64 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 13.64 for Q4 2025, up 60.08% from a year ago — trailing twelve months through Dec 2025 was 17.14 (up 460.99% YoY), and the annual figure for FY2025 was 17.14, up 460.99%.
  • Interest Coverage Ratio for Q4 2025 was 13.64 at Rigel Pharmaceuticals, down from 15.01 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for RIGL hit a ceiling of 86.09 in Q1 2021 and a floor of 22.79 in Q2 2022.
  • Median Interest Coverage Ratio over the past 5 years was 1.07 (2024), compared with a mean of 2.37.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 207.17% in 2022 and later skyrocketed 14700.2% in 2025.
  • Rigel Pharmaceuticals' Interest Coverage Ratio stood at 16.49 in 2021, then skyrocketed by 111.39% to 1.88 in 2022, then tumbled by 45.11% to 1.03 in 2023, then surged by 726.35% to 8.52 in 2024, then surged by 60.08% to 13.64 in 2025.
  • The last three reported values for Interest Coverage Ratio were 13.64 (Q4 2025), 15.01 (Q3 2025), and 32.61 (Q2 2025) per Business Quant data.